Skip to main content
. 2023 Feb 14;9(2):e13709. doi: 10.1016/j.heliyon.2023.e13709

Table 3.

Retention times (tR), MS data for identification of HAase inhibitors in CME using QTOF MS and Effect of candidate inhibitors on BD% and CBD%.

No. TR (min) Name Molecular formula M/Z [M − H] MS/MS spectra BD(%) CBD(%)
9 11.02 Eriodictyol-7-O-glucoside C21H22O11 449.1087 287.0553; 197.8070; 151.0034; 135.0451; 61.9890 86.72 41.59
10 11.56 Luteoloside C21H20O11 447.0933 285.0397; 197.8072; 151.0093; 61.9884 95.35 51.86
11 12.01 Luteolin-7-O-glucuronide C21H18O12 461.0721 285.0387; 197.0379; 61.9889 19.97 1.99
13 13.55 3,4-dicaffeoylquinic acid C25H24O12 515.1216 353.0884; 191.0562; 135.0458; 61.9885 20.81 −1.07
15 14.67 3,5-dicaffeoylquinic acid C25H24O12 515.1193 353.0852; 191.0553; 179.0337; 135.0452; 61.9885 19.38 −0.90
17 15.38 Apigenin 7-O-glucoside C21H20O10 431.1009 431.0984; 268.0371 96.98 47.63
20 16.62 4,5-dicaffeoylquinic acid C25H24O12 515.1209 353.0862; 191.0557; 179.0345; 135.0447 23.44 −1.08
21 16.85 Diosmetin 7-O- glucosidea C22H22O11 507.1168 461.1024; 299.0543; 284.0290; 197.8080; 61.9883 98.01 59.14
a

[M + FA-H].